Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase in bovine adrenal chromaffin cells via a pertussis toxin-sensitive process

J. Zhu, Wei Li, M. L. Toews, T. D. Hexum

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The effect of neuropeptide Y (NPY) on adenylate cyclase activity and the role of G-proteins mediating NPY's effect were investigated in cultured bovine adrenal chromaffin cells. The equilibrium binding of [125I]NPY to sucrose gradient purified bovine adrenal medulla plasma membranes revealed high- (GTPγS sensitive) and low-affinity binding sites with calculated IC50 values of 0.27 nM and 0.14 μM, respectively. Inhibition of forskolin- stimulated cyclic AMP accumulation was dependent upon the NPY concentration (IC50 = 0.9 nM) and independent of cyclic AMP (cAMP) phosphodiesterase activity. NPY-related peptides, except peptide YY, and NPY fragments exhibited minimal inhibitory activity. The inhibitory effect of NPY on forskolin-stimulated adenylate cyclase activity was completely abolished by pretreatment of the cells with pertussis toxin (PTX). Incubation of membranes with PTX and [32P]nicotinamide adenine dinucleotide revealed a protein band with an apparent molecular mass of 41 kDa. The time course and dose dependence of PTX pretreatment for in vitro ADP-ribosylation were similar to those for PTX to attenuate the NPY effect on forskolin-stimulated adenylate cyclase activity. The direct relation between the NPY receptor and the PTX- sensitive G-protein was further was shown by the ability of NPY to inhibit PTX-catalyzed in vitro ADP-ribosylation. ADP-ribosylation of the 41-kDa protein was partially inhibited by 5'-guanylylimidodiphosphate and further inhibited by high concentrations of NPY. An antibody against G(i1/i2)α1 recognized two species of which a 41-kDa protein comigrated with the PTX substrate. These results demonstrate that NPY inhibits adenylate cyclase activity in cultured bovine adrenal chromaffin cells through a receptor- linked PTX-sensitive G-protein, presumably G(i)2.

Original languageEnglish
Pages (from-to)1479-1486
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume263
Issue number3
StatePublished - Dec 1 1992
Externally publishedYes

Fingerprint

Chromaffin Cells
Neuropeptide Y
Pertussis Toxin
Colforsin
Adenylyl Cyclases
GTP-Binding Proteins
Adenosine Diphosphate
Cyclic AMP
Inhibitory Concentration 50
Neuropeptide Y Receptors
Peptide YY
Proteins
Adrenal Medulla
Phosphoric Diester Hydrolases
NAD
Sucrose
Binding Sites
Cell Membrane

ASJC Scopus subject areas

  • Pharmacology

Cite this

Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase in bovine adrenal chromaffin cells via a pertussis toxin-sensitive process. / Zhu, J.; Li, Wei; Toews, M. L.; Hexum, T. D.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 263, No. 3, 01.12.1992, p. 1479-1486.

Research output: Contribution to journalArticle

@article{465f50e6b2a345d496b8fc18812ae9b2,
title = "Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase in bovine adrenal chromaffin cells via a pertussis toxin-sensitive process",
abstract = "The effect of neuropeptide Y (NPY) on adenylate cyclase activity and the role of G-proteins mediating NPY's effect were investigated in cultured bovine adrenal chromaffin cells. The equilibrium binding of [125I]NPY to sucrose gradient purified bovine adrenal medulla plasma membranes revealed high- (GTPγS sensitive) and low-affinity binding sites with calculated IC50 values of 0.27 nM and 0.14 μM, respectively. Inhibition of forskolin- stimulated cyclic AMP accumulation was dependent upon the NPY concentration (IC50 = 0.9 nM) and independent of cyclic AMP (cAMP) phosphodiesterase activity. NPY-related peptides, except peptide YY, and NPY fragments exhibited minimal inhibitory activity. The inhibitory effect of NPY on forskolin-stimulated adenylate cyclase activity was completely abolished by pretreatment of the cells with pertussis toxin (PTX). Incubation of membranes with PTX and [32P]nicotinamide adenine dinucleotide revealed a protein band with an apparent molecular mass of 41 kDa. The time course and dose dependence of PTX pretreatment for in vitro ADP-ribosylation were similar to those for PTX to attenuate the NPY effect on forskolin-stimulated adenylate cyclase activity. The direct relation between the NPY receptor and the PTX- sensitive G-protein was further was shown by the ability of NPY to inhibit PTX-catalyzed in vitro ADP-ribosylation. ADP-ribosylation of the 41-kDa protein was partially inhibited by 5'-guanylylimidodiphosphate and further inhibited by high concentrations of NPY. An antibody against G(i1/i2)α1 recognized two species of which a 41-kDa protein comigrated with the PTX substrate. These results demonstrate that NPY inhibits adenylate cyclase activity in cultured bovine adrenal chromaffin cells through a receptor- linked PTX-sensitive G-protein, presumably G(i)2.",
author = "J. Zhu and Wei Li and Toews, {M. L.} and Hexum, {T. D.}",
year = "1992",
month = "12",
day = "1",
language = "English",
volume = "263",
pages = "1479--1486",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase in bovine adrenal chromaffin cells via a pertussis toxin-sensitive process

AU - Zhu, J.

AU - Li, Wei

AU - Toews, M. L.

AU - Hexum, T. D.

PY - 1992/12/1

Y1 - 1992/12/1

N2 - The effect of neuropeptide Y (NPY) on adenylate cyclase activity and the role of G-proteins mediating NPY's effect were investigated in cultured bovine adrenal chromaffin cells. The equilibrium binding of [125I]NPY to sucrose gradient purified bovine adrenal medulla plasma membranes revealed high- (GTPγS sensitive) and low-affinity binding sites with calculated IC50 values of 0.27 nM and 0.14 μM, respectively. Inhibition of forskolin- stimulated cyclic AMP accumulation was dependent upon the NPY concentration (IC50 = 0.9 nM) and independent of cyclic AMP (cAMP) phosphodiesterase activity. NPY-related peptides, except peptide YY, and NPY fragments exhibited minimal inhibitory activity. The inhibitory effect of NPY on forskolin-stimulated adenylate cyclase activity was completely abolished by pretreatment of the cells with pertussis toxin (PTX). Incubation of membranes with PTX and [32P]nicotinamide adenine dinucleotide revealed a protein band with an apparent molecular mass of 41 kDa. The time course and dose dependence of PTX pretreatment for in vitro ADP-ribosylation were similar to those for PTX to attenuate the NPY effect on forskolin-stimulated adenylate cyclase activity. The direct relation between the NPY receptor and the PTX- sensitive G-protein was further was shown by the ability of NPY to inhibit PTX-catalyzed in vitro ADP-ribosylation. ADP-ribosylation of the 41-kDa protein was partially inhibited by 5'-guanylylimidodiphosphate and further inhibited by high concentrations of NPY. An antibody against G(i1/i2)α1 recognized two species of which a 41-kDa protein comigrated with the PTX substrate. These results demonstrate that NPY inhibits adenylate cyclase activity in cultured bovine adrenal chromaffin cells through a receptor- linked PTX-sensitive G-protein, presumably G(i)2.

AB - The effect of neuropeptide Y (NPY) on adenylate cyclase activity and the role of G-proteins mediating NPY's effect were investigated in cultured bovine adrenal chromaffin cells. The equilibrium binding of [125I]NPY to sucrose gradient purified bovine adrenal medulla plasma membranes revealed high- (GTPγS sensitive) and low-affinity binding sites with calculated IC50 values of 0.27 nM and 0.14 μM, respectively. Inhibition of forskolin- stimulated cyclic AMP accumulation was dependent upon the NPY concentration (IC50 = 0.9 nM) and independent of cyclic AMP (cAMP) phosphodiesterase activity. NPY-related peptides, except peptide YY, and NPY fragments exhibited minimal inhibitory activity. The inhibitory effect of NPY on forskolin-stimulated adenylate cyclase activity was completely abolished by pretreatment of the cells with pertussis toxin (PTX). Incubation of membranes with PTX and [32P]nicotinamide adenine dinucleotide revealed a protein band with an apparent molecular mass of 41 kDa. The time course and dose dependence of PTX pretreatment for in vitro ADP-ribosylation were similar to those for PTX to attenuate the NPY effect on forskolin-stimulated adenylate cyclase activity. The direct relation between the NPY receptor and the PTX- sensitive G-protein was further was shown by the ability of NPY to inhibit PTX-catalyzed in vitro ADP-ribosylation. ADP-ribosylation of the 41-kDa protein was partially inhibited by 5'-guanylylimidodiphosphate and further inhibited by high concentrations of NPY. An antibody against G(i1/i2)α1 recognized two species of which a 41-kDa protein comigrated with the PTX substrate. These results demonstrate that NPY inhibits adenylate cyclase activity in cultured bovine adrenal chromaffin cells through a receptor- linked PTX-sensitive G-protein, presumably G(i)2.

UR - http://www.scopus.com/inward/record.url?scp=0026969024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026969024&partnerID=8YFLogxK

M3 - Article

VL - 263

SP - 1479

EP - 1486

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -